InsidersTradesSigma
Track the Healius Limited stock price and the full management transaction log of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the supervision of ASX. Operating in the Health Care sector, Healius Limited has recorded 12 insider filings. Market capitalisation: €290.5m. The latest transaction was reported on 18 August 2026 (Purchase). Among the most active insiders: its controlled bodies corporate listed in Annexure A. Every trade is openly available.
12
Insider Decl.
n/a
Thresholds
€12,203
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Healius Limited Hold (neutral), based on 10 analysts. Average price target: A$0.50.
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,135 of 28,803 companies
43.9
score / 100
Value52
Quality36
FCF yld67%
Earn yld-46%
EV/EBITDA·
ROE-108%
Gross mgn84%
Net mgn-11%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 August 2026
Declarations12 total
ShareASXISIN AU0000033359ASX:2924-03108338-2A1682964
ShareASXISIN AU0000033359ASX:2924-03099875-2A1677246
ShareASXISIN AU0000033359ASX:2924-03095343-2A1674626
ShareASXISIN AU0000033359ASX:2924-03093884-2A1673899
22,978 shares@ A$0.87040.0000% mcap100.0% of flowShareASXISIN AU0000033359ASX:2924-03081721-2A1667897
12 of 12 declarations
About Healius Limited
Healius Limited is an Australian company specializing in health and diagnostic services. It primarily operates on the Australian Securities Exchange (XASX).
